🔎 Trials Near Me

Beranda › Kanker Kolorektal › New York › Queens

Uji klinis Kanker Kolorektal di Queens, NY

31 studi untuk Kanker Kolorektal mencari peserta di lokasi sekitar Queens (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

Menerima peserta
  • Jamaica Hospital Medical Center (Data Collection Only), Richmond Hill · 1 mi jauhnya
  • Queens Cancer Center of Queens Hospital, Jamaica · 2 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT04751435

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Menerima pesertaFase 3
  • Northwell Health Center for Advanced Medicine. /ID# 279590, Lake Success · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07525206

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1
  • START New York Long Island LLC, Lake Success · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06270706

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Menerima pesertaFase 2
  • Northwell Health Physicians Partners Radiation Medicine at Queens, Forest Hills · 3 mi jauhnya
  • Queens Cancer Center, Rego Park · 3 mi jauhnya
  • The New York Hospital Medical Center of Queens, Flushing · 6 mi jauhnya
  • dan 2 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05673148

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Queens Hospital Center, Jamaica · 2 mi jauhnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Menerima pesertaFase 3
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park · 9 mi jauhnya
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon · 27 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07222800

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Menerima pesertaFase 1/2
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0327), Mineola · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06428409

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Menerima pesertaFase 3
  • Perlmutter Cancer Center at NYU Long Island, Mineola · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06750094

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • GSK Investigational Site, New Hyde Park · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07277270

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Menerima pesertaFase 3
  • Perlmutter Cancer Center at NYU Long Island, Mineola · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06662786

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Menerima pesertaFase 3
  • Memorial Sloan Kettering Nassau, Uniondale · 13 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05863195

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Menerima pesertaFase 2/3
  • Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 mi jauhnya
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, Mineola · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07221357

A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

Menerima pesertaFase 2
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07227636

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Menerima pesertaFase 1/2
  • Northwell Health / RJ Zuckerberg Cancer Center, Lake Success · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06445062

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

Menerima pesertaFase 1
  • New York Cancer & Blood Specialists - New Hyde Park, New Hyde Park · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT04929223

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Menerima pesertaFase 3
  • Clinical Study Site, Mineola · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07228832

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Menerima pesertaFase 1
  • NYU Langone Health - Long Island, Mineola · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06400472

A Study of MGC026 in Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • START-New York Long Island, Lake Success · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06242470

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Menerima pesertaFase 1/2
  • Clinical Research Alliance, Inc, Westbury · 14 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT06330064

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • Northwell Health Cancer Institute, Lake Success · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT04657068

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Menerima pesertaFase 3
  • MSK Nassau, Uniondale · 13 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT05253651

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • START New York, Lake Success · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT06657144

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Menerima pesertaFase 1
  • START New York Long Island, LLC, Lake Success · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Jun 2026 · NCT07503808

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • START New York Long Island, LLC, Lake Success · 9 mi jauhnya
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Jun 2026 · NCT07540572

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

Menerima peserta
  • VA New York Harbor Healthcare System - St. Albans Community Living Center, Jamaica · 2 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT06559059

Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer

Menerima pesertaStudi observasional
  • Memorial Sloan Kettering Nassau, Rockville Centre · 10 mi jauhnya
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 7 Apr 2026 · NCT04812912

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Menerima pesertaStudi observasional
  • Queens Hospital Center, Jamaica · 2 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06418204

A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer

Menerima pesertaFase 2
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Feb 2026 · NCT06130280

Collection of Information to Better Understand Young Onset Colorectal Cancer

Menerima pesertaStudi observasional
  • Memorial Sloan Kettering Nassau, Rockville Centre · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Feb 2026 · NCT04489238

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Menerima pesertaStudi observasional
  • Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jan 2026 · NCT06073431

Uji klinis Kanker Kolorektal di kota lain

Studi lain di Queens

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.